Annual report pursuant to Section 13 and 15(d)

Supplemental Financial Information

v3.20.1
Supplemental Financial Information
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Supplemental Financial Information
19. Supplemental Financial Information

Quarterly Results of Operations (Unaudited)
 
The following table presents the unaudited statements of operations data for each of the eight quarters in the period ended December 31, 2019. The information has been presented on the same basis as the audited financial statements and all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts below to present fairly the unaudited quarterly results when read in conjunction with the audited financial statements and related notes. The operating results for any quarter should not be relied upon as necessarily indicative of results for any future period.

Unaudited Quarterly Results of Operations 
(in thousands, except share and per share amounts) 

  Three months ended  
March 31,
2019
June 30,
2019
September 30,
2019
December 31,
2019
Total for year
2019
Product sales $ 437    $ 1,483    $ 2,361    $ 593    $ 4,874   
Operating cost and expense
Cost of product sales 4,681    7,185    8,231    4,702    24,799   
Research and development cost 620    338    282    315    1,555   
General and administrative expense 4,016    4,335    5,107    5,856    19,314   
Total operating expenses 9,317    11,858    13,620    10,873    45,668   
Loss from operations (8,880)   (10,375)   (11,259)   (10,280)   (40,794)  
Other income and expense
Insurance proceeds net of related expenses —    —    —    (792)   (792)  
Interest expense (2,889)   (203)   (142)   (243)   (3,477)  
Interest and other income 63    77    85    45    270   
Total other expense, net (2,826)   (126)   (57)   (990)   (3,999)  
Loss before income tax expense (11,706)   (10,501)   (11,316)   (11,270)   (44,793)  
Income tax expense (2)   —    —    —    (2)  
Net loss $ (11,708)   $ (10,501)   $ (11,316)   $ (11,270)   $ (44,795)  
Weighted average shares outstanding, basic and diluted 43,514,225    50,757,448    57,053,982    57,523,283    52,263,885   
Basic and diluted net loss per share $ (0.27)   $ (0.21)   $ (0.20)   $ (0.20)   $ (0.86)  
 
  Three months ended  
March 31,
2018
June 30,
2018
September 30,
2018
December 31,
2018
Total for year
2018
Product sales $ 1,726    $ 483    $ 1,169    $ 1,071    $ 4,449   
Operating cost and expense
Cost of product sales 5,436    4,600    6,453    6,272    22,761   
Research and development cost 1,475    1,203    967    857    4,502   
General and administrative expense 1,775    3,913    2,174    6,352    14,214   
Total operating expenses 8,686    9,716    9,594    13,481    41,477   
Loss from operations (6,960)   (9,233)   (8,425)   (12,410)   (37,028)  
Other income and expense
Interest expense (587)   (719)   (919)   (1,222)   (3,447)  
Interest and other income 17    25    81    100    223   
Total other expense, net (570)   (694)   (838)   (1,122)   (3,224)  
Loss before income tax expense (7,530)   (9,927)   (9,263)   (13,532)   (40,252)  
Income tax expense (2)   —    —    —    (2)  
Net loss $ (7,532)   $ (9,927)   $ (9,263)   $ (13,532)   $ (40,254)  
Weighted average shares outstanding, basic and diluted 27,768,008    30,134,995    38,779,710    38,905,282    34,154,826   
Basic and diluted net loss per share $ (0.27)   $ (0.33)   $ (0.24)   $ (0.35)   $ (1.18)